VERA THERAPEUTICS INC
VERANASDAQ🏆 #1895 by market capEarnings Nov 5US Equity
$31.03▲ $0.08 (+0.27%)
Latest quoteTrack VERA
Get earnings, price moves & breaking news on Telegram
24h▲ 0.3%
7d▲ 6.7%
14d▲ 8.6%
30d▼ 4.2%
ytd▼ 38.7%
1y▲ 5.9%
🏦Market Cap
$2.24B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
VERA THERAPEUTICS INC
VERAAnalyst Ratings
Price
$31.03
Total
14
Raised
2
Lowered
0
Avg PT
$80.89
H / L
$125 / $34
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
JP Morgan | Reiterated | Overweight | 2026-09-08 | $38.00 | +22.50% |
Wedbush | Reiterated | Neutral | 2026-08-17 | $43.00 | +38.60% |
HC Wainwright & Co. | Reiterated | Buy | 2026-08-12 | — | — |
Guggenheim | Reiterated | Buy | 2026-07-08 | $76.00 | +145.00% |
TD Cowen | Reiterated | Buy | 2026-07-08 | — | — |
B of A Securities | Reiterated | Buy | 2026-07-07 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2026-05-15 | — | — |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2026-03-11 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-12-19 | $90.00 | +190.10% |
Scotiabank | Reiterated | Sector Outperform | 2025-06-02 | $65.00 | +109.50% |
Cantor Fitzgerald | Reiterated | Overweight | 2025-05-07 | — | — |
Raymond James | Reiterated | Strong Buy | 2024-05-10 | $84.00 | +170.70% |
Jefferies | Upgraded | Hold → Buy | 2023-11-10 | $60.00 | +93.40% |
Cowen & Co. | Reiterated | Outperform | 2021-06-08 | — | — |
Institution
JP Morgan
Reiterated · Overweight · 2026-09-08
$38.00
+22.50%
Wedbush
Reiterated · Neutral · 2026-08-17
$43.00
+38.60%
HC Wainwright & Co.
Reiterated · Buy · 2026-08-12
—
—
Guggenheim
Reiterated · Buy · 2026-07-08
$76.00
+145.00%
TD Cowen
Reiterated · Buy · 2026-07-08
—
—
B of A Securities
Reiterated · Buy · 2026-07-07
—
—
Evercore ISI Group
Reiterated · Outperform · 2026-05-15
—
—
Wolfe Research
Upgraded · Peer Perform → Outperform · 2026-03-11
—
—
Goldman Sachs
Reiterated · Buy · 2025-12-19
$90.00
+190.10%
Scotiabank
Reiterated · Sector Outperform · 2025-06-02
$65.00
+109.50%
Cantor Fitzgerald
Reiterated · Overweight · 2025-05-07
—
—
Raymond James
Reiterated · Strong Buy · 2024-05-10
$84.00
+170.70%
Jefferies
Upgraded · Hold → Buy · 2023-11-10
$60.00
+93.40%
Cowen & Co.
Reiterated · Outperform · 2021-06-08
—
—
One row per institution · price target from the firm's latest published target